Skip to main content
Premium Trial:

Request an Annual Quote

NIH Calls for Grant Applications for Collaborative Molecular, Genomic Studies of Behavior

NEW YORK , Oct. 31 (GenomeWeb News) - The National Institutes of Health issued last week a call for collaborative-research grant applications focused on using molecular and/or genomic approaches to address questions about basic mechanisms of behavior in animal models.

 

A

ccording to the NIH, the goal of the initiative is to facilitate collaborations between behavioral scientists and investigators with expertise in state-of-the-art molecular biology and/or genomics.

 

"It is anticipated that ... these collaborations will enable the investigators to address questions about the mechanisms of behavior that neither [behavioral scientists nor molecular biology/genomics researchers] alone could tackle, and to become familiar with aspects of each other's disciplines," the NIH said.

 

"There is also a paucity of animal models for many aspects of normal and abnormal human behavior, and some existing models are suboptimal. Accordingly, a second objective of this initiative is development of new animal models and enhancement of existing animal models for normal or abnormal human behavior.," the NIH added.

 

The NIH said that the grant program requires that one of the collaborators be "a behavioral scientist who has little or no experience doing molecular or genomic analysis of any phenotype, in any organism." Another investigator should have expertise in molecular biology and/or genomics but little or no experience analyzing any aspect of behavior, in any organism, it added.

 

The grants will be awarded using the NIH Research Project Grant mechanism. The grants are being awarded by the National Institute of General Medical Sciences and the National Institute of Child Health and Human Development, but no specific funds have been set aside for this announcement.

 

Additional details about the funding opportunity can be found here.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.